11
2021-05
A few days ago, Shanghai Jiaotong University led a team of leading universities and high-tech companies in China, led by Professor Xu Kai of the School of Mechanical and Power Engineering, to independently develop a surgical robot for single hole endoscopic surgery,Completed the first radical prostatectomy under single hole in China at the First Hospital of Jiaxing City, Zhejiang Province
07
2021-05
【KOL Tripartite Bank】Key Success of Excellent Medical Device Innovation Project......
The characteristics of excellent medical device innovation projects: First, the project is just needed in clinical, demand oriented. Second, there are technical barriers or resource barriers, at least 2-3 years ahead of the market.Third, there is enough market volume. At least more than 300 million revenue can be generated in China, and the market space of the track will reach 1 billion
07
2021-05
Yang Fan Fund Advisory Committee was established
On January 13, 2021, the Yangfan Fund Advisory Committee under Tianfeng Capital was officially established- According to the Partnership Agreement, the Advisory Committee has the following powers on the following matters (1)Vote on the extension of the duration of the partnership in accordance with the partnership agreement; Science and innovation fund has one veto on this voting matter- (2)Vote on the transfer of partnership interests by the general partner to non related parties according to the partnership agreement-(3)It shall be submitted according to the partnership agreement
29
2021-11
The company was invited to attend Medtronic Strategic Priorities Summit
On August 25, 2020, Mr. Guan Jifeng, founding partner of Tianfeng, was invited to participate in the internal SPS meeting (Strategic Priority Summit) of Medtronic, and participated in the panel discussion,The topic of discussion was "Some thoughts on Chinese local medical technology companies". In the panel discussion, four parts
01
2021-12
Tianfeng A round project Peijia Medical was successfully listed
Tianfeng Round A took the lead in offering TS and investing, while Round B continued to pursue investment, and conducted most of the business negotiations for the merger of Peijia Hejiaqi. With the listing of Peijia Medical on May 15, its current market value has exceeded HK $17 billion.Forecast of Tianfeng
02
2021-12
Tianfeng Capital was the exclusive third meeting place of Zhongguancun Pharmaceutical Project Roadshow...
On April 28, 2020, Beijing Fund Town, Beijing Zhongguancun Life Science Park Biomedical Technology Incubation Co., Ltd. and Haidian Haichuang Park jointly held the "Biomedical Special Session of Zhongguancun Overseas Students Enterprise Quality Project Promotion Conference",The organizer specially invited Tang Hao, the executive partner and investment director of Tianfeng team, to be the only guest to comment on the eight roadshow projects of the whole event. This activity adopts
30
2021-11
Congratulations on Nanxin Pharmaceutical's landing on the Science Innovation Board, one of the investment portfolios of Tianfeng team
Nanxin Pharmaceutical issued 35 million shares this time at a price of 34.94 yuan per share. The company's securities code is 688189, and its price earnings ratio is 55.48 times. Today's opening price was 69.00 yuan/share, up 97.48
29
2021-11
Female colleagues have a full day off on March 8th
After discussion at the partners' meeting of the company, it was unanimously agreed that female colleagues of the company would have a full day holiday on March 8, and all female compatriots worked hard!
30
2021-11
The project invested by the company is listed on the Eppon Medical Growth Enterprise Market
Aipeng Medical 300753 was officially listed in Shenzhen Stock Exchange. After the opening, the stock price rose by the limit, hitting 22.75 yuan at the highest in the session, up 43.99%.
29
2021-11
My colleagues celebrate their birthday in August
The company celebrates the birthday of colleagues who celebrate their birthdays in August in Beijing.
s